Sharpening Fibromyalgia Diagnosis and Management Skills: Improving the Patient Experience

 

 

Lesley M. Arnold, MD (Chair)

Professor of Psychiatry and Behavioral Neuroscience

University of Cincinnati College of Medicine

Cincinnati, OH

 

Jan F. Chambers

President/Founder

National Fibromyalgia & Chronic Pain Association

Logan, UT

 

Bill H. McCarberg, MD

Adjunct Assistant Clinical Professor

University of California

Founder

Chronic Pain Management Program

Kaiser Permanente – San Diego

San Diego, CA

 

Annette Schwind

Fibromyalgia Patient

Pequannock, NJ

 

The educational design of this activity addresses the needs of primary care practitioners—physicians, nurse practitioners, and physician assistants—as well as pain specialists, rheumatologists, and neurologists involved in the treatment of patients with fibromyalgia.

 

Fibromyalgia affects an estimated 10 million Americans, often interfering with their ability to function. It is marked by chronic widespread pain and a host of somatic symptoms that negatively affect daily tasks and major life decisions. This lively and diverse CME-certified on-demand webinar focuses on how to diagnose and treat fibromyalgia (pharmacologically and nonpharmacologically), how to manage the whole patient, and how to foster a productive relationship with patients dealing with this complex condition. Clinicians must recognize that, to successfully manage the fibromyalgia patient, a multifaceted, individualized approach integrating all of these strategies is required. Too often, healthcare professionals consider fibromyalgia a psychological illness rather than a true medical condition. This webinar—conducted by two fibromyalgia expert clinicians, a fibromyalgia patient advocacy professional, and a fibromyalgia patient—will educate healthcare practitioners, through evidence-based data and real-life experiences, on the fact that those beliefs are no longer accepted. It will instruct learners on how to start a productive and respectful clinician/patient relationship that will lead to the improvement of care and quality of life of fibromyalgia patients.

 

Upon proper completion of this activity, participants should be better able to:

 

The content of this webinar is viewable on-demand, and participants may navigate through the chapters in any order and at their own pace at their convenience.

 

 

 

 

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

Lesley M. Arnold, MD

Grant/Research Support: AstraZeneca; Eli Lilly and Company; Forest Laboratories, Inc.; Pfizer Inc; Takeda Pharmaceutical Company Limited; Theravance, Inc.

Retained Consultant: Daichii Sankyo Company, Ltd.; Dainippon Sumitomo Pharma Co., Ltd; Pfizer Inc; Purdue Pharma LP; Theravance, Inc.

Speakers Bureau: Pfizer Inc.

 

Jan F. Chambers

 

Bill H. McCarberg, MD

Retained Consultant: Iroko Pharmaceuticals, LLC; Pfizer Inc; Salix Pharmaceuticals, Inc.; Zogenix, Inc.

 

Annette Schwind

 

 

Paradigm Medical Communications, LLC staff members Nancy Salerno and Audrie Tornow, CCMEP, and consultant scientific director Rae Marie Gleason have no financial conflicts to disclose.

 

Global Education Group staff members Amanda Glazar, PhD, and Ashley Marosca, RN, MSN, have no financial conflicts to disclose.

 

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Global Education Group designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.75 hours of Category 1 credit for completing this program.

 

Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 11021.

This program has been approved for 1.75 contact hours of continuing education (which includes 0.25 hours of pharmacology).

 

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.

 

 

This activity is supported by an educational grant from Forest Laboratories, Inc.  

 

In order to receive credit for this activity, the participant must:

 

There is no fee required for participation in this activity.

 

This activity is designed as a self-running Flash presentation. In the event that you need this plug-in, a link to download the required Flash Player has been provided below.

 

Flash Player 10 or later required; download at: http://www.adobe.com/support/flashplayer/downloads.html

 

For your convenience, you may use the buttons along the top of the screen to navigate between chapters.

 

For Windows: Internet Explorer 7 or higher, Firefox 4.0, Safari 3, Google Chrome, Opera 9.5

For Mac: Safari 3, Firefox 4.0, Google Chrome

Linux: Firefox 4.0

 

Technical Support:If you have any technical problems or playback issues, please send an email to: contactus@paradigmmc.com.

 

RESOLUTION OF CONFLICT OF INTEREST
Paradigm Medical Education, LLC (Paradigm) and Global Education Group (Global) require instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Paradigm and Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

 

©2013 Paradigm Medical Communications, LLC, except where noted. This web presentation may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.

 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Paradigm and Global do not recommend the use of any agent outside of the labeled indications. 

 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

CONTACT US
For information about the accreditation of this program, please contact Global at (303) 395-1782 or inquire@globaleducationgroup.com.